Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/31714
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Millington, William R. | - |
dc.date.accessioned | 2023-03-23T08:50:36Z | - |
dc.date.available | 2023-03-23T08:50:36Z | - |
dc.date.issued | 2003-09 | - |
dc.identifier.citation | Gürün, M.S. vd. (2003). “Choline potentiates the pressor response evoked by glycyl-glutamine or naloxone in haemorrhaged rats”. Clinical and Experimental Pharmacology and Physiology, 30(9), 640-642. | en_US |
dc.identifier.issn | 0305-1870 | - |
dc.identifier.uri | https://doi.org/10.1046/j.1440-1681.2003.03886.x | - |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/full/10.1046/j.1440-1681.2003.03886.x | - |
dc.identifier.uri | http://hdl.handle.net/11452/31714 | - |
dc.description.abstract | 1. Severe blood loss initially lowers arterial pressure through a central mechanism that is thought to involve opioid and cholinergic neurons. The present study tested the hypothesis that simultaneous administration of a cholinergic agonist and an opioid receptor antagonist would produce a synergistic effect in the treatment of haemorrhage. Specifically, we tested whether choline, a precursor of acetylcholine, potentiates the pressor effect of the beta-endorphin derived peptide glycylglutamine (Gly-Gln) or the opioid receptor antagonist naloxone following acute haemorrhage. 2. Conscious rats were treated intracerebroventricularly (i.c.v.) with choline chloride ( 180 nmol) alone or combined with Gly-Gln ( 10 nmol) or naloxone ( 10 nmol) 2 min after blood withdrawal (2.5 mL/100 g bodyweight over 20 min) was completed; mean arterial pressure and heart rate were monitored for 30 min. 3. Combined treatment with choline and Gly-Gln elevated mean arterial pressure but did not affect heart rate significantly. Choline and Gly-Gln had no effect on cardiovascular function when administered alone to haemorrhaged rats or when given together to normotensive animals. Choline also potentiated the pressor and tachycardic effect of naloxone in haemorrhaged rats. 4. These data show that choline potentiates the pressor effect of Gly-Gln and naloxone in haemorrhaged rats. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Pharmacology and pharmacy | en_US |
dc.subject | Physiology | en_US |
dc.subject | Choline | en_US |
dc.subject | Cholinergic system | en_US |
dc.subject | Glycyl-glutamine | en_US |
dc.subject | Gly-gln | en_US |
dc.subject | Haemorrhage | en_US |
dc.subject | Hypotension | en_US |
dc.subject | Opioid | en_US |
dc.subject | Acetylcholine turnover | en_US |
dc.subject | Morphine | en_US |
dc.subject | Shock | en_US |
dc.subject | Physostigmine | en_US |
dc.subject | Reversal | en_US |
dc.subject | Depression | en_US |
dc.subject | Antagonism | en_US |
dc.subject | Endorphin | en_US |
dc.subject | Decrease | en_US |
dc.subject | Brain | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Blood pressure | en_US |
dc.subject.mesh | Choline | en_US |
dc.subject.mesh | Dipeptides | en_US |
dc.subject.mesh | Drug synergism | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Heart rate | en_US |
dc.subject.mesh | Hemorrhage | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Naloxone | en_US |
dc.subject.mesh | Pressoreceptors | en_US |
dc.subject.mesh | Rats | en_US |
dc.subject.mesh | Rats, Sprague-Dawley | en_US |
dc.title | Choline potentiates the pressor response evoked by glycyl-glutamine or naloxone in haemorrhaged rats | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000185110700006 | tr_TR |
dc.identifier.scopus | 2-s2.0-16744364994 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Farmakoloji Anabilim Dalı. | tr_TR |
dc.identifier.startpage | 640 | tr_TR |
dc.identifier.endpage | 642 | tr_TR |
dc.identifier.volume | 30 | tr_TR |
dc.identifier.issue | 9 | tr_TR |
dc.relation.journal | Clinical and Experimental Pharmacology and Physiology | en_US |
dc.contributor.buuauthor | Gürün, Mine Sibel | - |
dc.contributor.buuauthor | Ulus, İsmail Hakkı | - |
dc.contributor.researcherid | AAG-8716-2019 | tr_TR |
dc.contributor.researcherid | D-5340-2015 | tr_TR |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.identifier.pubmed | 12940881 | tr_TR |
dc.subject.wos | Pharmacology and pharmacy | en_US |
dc.subject.wos | Physiology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q3 (Pharmacology & pharmacy) | en_US |
dc.wos.quartile | Q2 (Physiology) | en_US |
dc.contributor.scopusid | 55664349700 | tr_TR |
dc.contributor.scopusid | 7004271086 | tr_TR |
dc.subject.scopus | Citicoline; Brain Ischemia; Glycerylphosphorylcholine | en_US |
dc.subject.emtree | Animal experiment | en_US |
dc.subject.emtree | Animal model | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Bleeding | en_US |
dc.subject.emtree | Body weight | en_US |
dc.subject.emtree | Cardiovascular function | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Drug effect | en_US |
dc.subject.emtree | Drug potentiation | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Heart rate | en_US |
dc.subject.emtree | Hemodynamic monitoring | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Mean arterial pressure | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Pressor response | en_US |
dc.subject.emtree | Rat | en_US |
dc.subject.emtree | Tachycardia | en_US |
dc.subject.emtree | Choline | en_US |
dc.subject.emtree | Cholinergic receptor stimulating agent | en_US |
dc.subject.emtree | Glycylglutamine | en_US |
dc.subject.emtree | Naloxone | en_US |
dc.subject.emtree | Opiate antagonist | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.